NL-OMON42995招募中不适用
*The use of fecal calprotectin in detecting immunotherapy induced colitis and feasibility for the use of immunohistochemical markers in patients receiving checkpoint inhibitors*- a pilot study - COLIT-1
ederlands Kanker Instituut0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age > 18 years
- •- Starting with anti CTLA-4 antibodies alone or in combination with anti PD-1 antibodies for a malignancy
- •- Signed informed consent
排除标准
- •There are no exclusion criteria for participation in this study
研究者
相似试验
招募中
不适用
The use of fecal calprotectin in detecting immunotherapy induced colitis and feasibility for the use of immunohistochemical markers in patients receiving checkpoint inhibitors’- a pilot studycolitisNL-OMON25248KI-AV50
招募中
Unknown
Study on the usefulness of fecal calprotectin in ulcerative colitis and the relevance of other biomarkerslcerative colitisJPRN-UMIN000052832Ehime University150
已完成
不适用
Can fecal calprotectin be a predictive marker for refractoriness in patients with ulcerative colitis ?lcerative colitisJPRN-UMIN000024146Showa University, School of Medicine100
已完成
不适用
Faecal calprotectin as a diagnostic test for IBD in children in primary careCrohn's diseaseinflammatory bowel disease10017969ulcerative colitisNL-OMON34153niversitair Medisch Centrum Groningen218
已完成
不适用
Relevance of fecal calprotectin as a biomarker to predict the outcome of Adalimumab therapy in Ulcerative Colitis patients.lcerative ColitisJPRN-UMIN000022104Hyogo College of Medicine, Department of Inflammatory Bowel Disease, Division of Internal Medicine54